We report a 55-year-old man with metastatic castration-resistant prostate cancer who developed a dramatic "scintigraphic flip" after the second cycle of ¹⁷⁷Lu-PSMA therapy. Post-th
Loading
Source
2 developments in the corpus
Latest
Everything in the corpus, newest first.
We report a 55-year-old man with metastatic castration-resistant prostate cancer who developed a dramatic "scintigraphic flip" after the second cycle of ¹⁷⁷Lu-PSMA therapy. Post-th
SEP 4, 2026 · JOURNAL ARTICLE
Clinical Nuclear Medicine
Single-case report demonstrating imaging methodology and concordance patterns in one patient; raises questions about imaging selection and tumor heterogeneity but lacks comparative data, control group, or outcome data to establish clinical utility.